title: Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2.
authors.affiliation: Department of Medicine, Mount Sinai Medical Center, New York, NY 10029.
authors.forename: C
authors.initials: C
authors.lastname: Cunningham-Rundles
authors.forename: K
authors.initials: K
authors.lastname: Kazbay
authors.forename: J
authors.initials: J
authors.lastname: Hassett
authors.forename: Z
authors.initials: Z
authors.lastname: Zhou
authors.forename: L
authors.initials: L
authors.lastname: Mayer
mesh_terms: D000917:Antibody Formation; D001402:B-Lymphocytes / Q000276:immunology; D017074:Common Variable Immunodeficiency / Q000276:immunology* / Q000628:therapy*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D007376:Interleukin-2 / Q000096:biosynthesis / Q000627:therapeutic use*; D015850:Interleukin-6 / Q000096:biosynthesis; D008213:Lymphocyte Activation; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D007136:Immunoglobulins; D007376:Interleukin-2; D015850:Interleukin-6; D011994:Recombinant Proteins